glp 1 by lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating New GLP-1 Pill Foundayo (Orforglipron)
Description
Green H, Tsitsi P, Markaki I, Aarsland D, Svenningsson P
However, CagriSema and retatrutide (both in late-stage development) more closely match tirzepatide weight loss results , with CagriSema achieving 20% and retatrutide achieving up to 29% body weight reduction in trials
Malavazos AE, Meregalli C, Sorrentino F, et al
Coming Thursday: How cancer patients view prior authorization Thanks for reading
Magnesium 9
